These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11707411)

  • 1. hADA3 is required for p53 activity.
    Wang T; Kobayashi T; Takimoto R; Denes AE; Snyder EL; el-Deiry WS; Brachmann RK
    EMBO J; 2001 Nov; 20(22):6404-13. PubMed ID: 11707411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
    Knights CD; Liu Y; Appella E; Kulesz-Martin M
    J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses.
    Yoon KA; Nakamura Y; Arakawa H
    J Hum Genet; 2004; 49(3):134-140. PubMed ID: 14986171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells.
    Zhang X; Xu LS; Wang ZQ; Wang KS; Li N; Cheng ZH; Huang SZ; Wei DZ; Han ZG
    FEBS Lett; 2004 Jul; 570(1-3):7-12. PubMed ID: 15251430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage activates p53 through a phosphorylation-acetylation cascade.
    Sakaguchi K; Herrera JE; Saito S; Miki T; Bustin M; Vassilev A; Anderson CW; Appella E
    Genes Dev; 1998 Sep; 12(18):2831-41. PubMed ID: 9744860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ING5 is a Tip60 cofactor that acetylates p53 in response to DNA damage.
    Liu N; Wang J; Wang J; Wang R; Liu Z; Yu Y; Lu H
    Cancer Res; 2013 Jun; 73(12):3749-60. PubMed ID: 23576563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin K as a direct transcriptional target of the p53 tumor suppressor.
    Mori T; Anazawa Y; Matsui K; Fukuda S; Nakamura Y; Arakawa H
    Neoplasia; 2002; 4(3):268-74. PubMed ID: 11988847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of transcriptional and phosphatase regulators as interaction partners of human ADA3, a component of histone acetyltransferase complexes.
    Zencir S; Sike A; Dobson MJ; Ayaydin F; Boros I; Topcu Z
    Biochem J; 2013 Mar; 450(2):311-20. PubMed ID: 23167988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage.
    Chao C; Saito S; Kang J; Anderson CW; Appella E; Xu Y
    EMBO J; 2000 Sep; 19(18):4967-75. PubMed ID: 10990460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of an ING1 growth regulator in transcriptional activation and targeted histone acetylation by the NuA4 complex.
    Nourani A; Doyon Y; Utley RT; Allard S; Lane WS; Côté J
    Mol Cell Biol; 2001 Nov; 21(22):7629-40. PubMed ID: 11604499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational modifications involved in the DNA damage response.
    Anderson CW; Appella E; Sakaguchi K
    J Protein Chem; 1998 Aug; 17(6):527. PubMed ID: 9723732
    [No Abstract]   [Full Text] [Related]  

  • 12. An essential role of human Ada3 in p53 acetylation.
    Nag A; Germaniuk-Kurowska A; Dimri M; Sassack MA; Gurumurthy CB; Gao Q; Dimri G; Band H; Band V
    J Biol Chem; 2007 Mar; 282(12):8812-20. PubMed ID: 17272277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-alpha induced p21(WAF1) but not Bax in colon cancer cells WiDr with mutated p53: important role of protein stabilization.
    Kobayashi N; Takada Y; Hachiya M; Ando K; Nakajima N; Akashi M
    Cytokine; 2000 Dec; 12(12):1745-54. PubMed ID: 11097743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
    Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
    Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305.
    Wang YH; Tsay YG; Tan BC; Lo WY; Lee SC
    J Biol Chem; 2003 Jul; 278(28):25568-76. PubMed ID: 12724314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p53 by protein inhibitor of activated Stat1 (PIAS1).
    Megidish T; Xu JH; Xu CW
    J Biol Chem; 2002 Mar; 277(10):8255-9. PubMed ID: 11788578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53.
    Sasaki T; Gan EC; Wakeham A; Kornbluth S; Mak TW; Okada H
    Genes Dev; 2007 Apr; 21(7):848-61. PubMed ID: 17403783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription.
    Yakovleva T; Kolesnikova L; Vukojević V; Gileva I; Tan-No K; Austen M; Lüscher B; Ekström TJ; Terenius L; Bakalkin G
    Biochem Biophys Res Commun; 2004 May; 318(2):615-24. PubMed ID: 15120643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
    Di Stefano V; Soddu S; Sacchi A; D'Orazi G
    Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.
    Vaziri H; Dessain SK; Ng Eaton E; Imai SI; Frye RA; Pandita TK; Guarente L; Weinberg RA
    Cell; 2001 Oct; 107(2):149-59. PubMed ID: 11672523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.